Publication | Open Access

Comparison of colistin–carbapenem, colistin–sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections

Antimicrobial SusceptibilityHealth SciencesAntibioticsMedicineAntibacterial AgentAntimicrobial TherapyMicrobiologyAntimicrobial AgentsOther Antibacterial AgentsAntimicrobial ChemotherapyBacterial ResistanceClinical MicrobiologyAntimicrobial ResistanceDrug Resistance